Frank Karbe insider trades
Open-market stock purchases and sales by Frank Karbe, Unknown at Phathom Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 24, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -11%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 19, 2026 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | — |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $1.7M |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $2.4M |
| Dec 10, 2025 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $1.6M |
Companies traded
- PHAT Phathom Pharmaceuticals, Inc: 1 buy, last May 19, 2026
- CDTX Cidara Therapeutics, Inc: other filings, last Jan 7, 2026
- BTTX Better Therapeutics, Inc: 3 buys, last Dec 18, 2023
- MYOV Myovant Sciences Ltd: 1 buy, 16 sales, last Jul 7, 2021
- ADRO Aduro Biotech, Inc: other filings, last May 5, 2020
- ABUS Arbutus Biopharma Corp: other filings, last Jun 21, 2017
- EXEL Exelixis, Inc: 2 buys, last Feb 15, 2014